Answer
During setmelanotide treatment, heart rate and blood pressure should be monitored at each medical visit, at least every 6 months, as part of standard clinical practice.
Sources for this answer
- IMCIVREE 10 mg/ml solution for injectionRhythm Pharmaceutical UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked